Filter
1608
Text search:
pharmaceutical
services
Featured
154
418
Language
Document type
762
340
258
88
87
22
20
12
9
5
4
1
Countries
73
73
67
63
47
40
37
37
32
31
26
25
25
24
21
20
20
20
20
19
19
18
15
15
14
14
12
12
11
11
9
9
9
8
7
6
6
5
5
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
714
98
81
71
38
26
15
2
Toolboxes
159
148
127
99
72
52
36
36
33
32
32
28
26
25
23
21
20
12
12
9
8
6
4
3
1
Value in Health Regional Issues 4 C (2014) 37-40
Towards the Peoples Health Assembly Book -4
Towards the Peoples Health Assembly Book -1
The use of the World Health Organization Health System Performance Assessment Framework
Towards a Healthier Botswana
First Revised Edition
March 2000
THE REPUBLIC OF BOTSWANA | MINISTRY OF HEALTH | DEPARTMENT OF PUBLIC HEALTH | NATIONAL MALARIA CONTROL PROGRAMME
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th
...
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Lessons from the STEP-TB Project.
Accessed November 2017.